ATRA-BA Hybrid, CAS 1037543-26-2

ATRA-BA Hybrid, CAS 1037543-26-2
SKU
CAY30982-5
Packaging Unit
5 mg
Manufacturer
Cayman Chemical

Availability: loading...
Price is loading...
Formulation: A solid

Formal Name: retinoic acid, 4-[(1-oxobutoxy)methyl]phenyl ester

Purity: ≥95%

Formula Markup: C31H40O4

Formula Weight: 476,7

Shelf life (days): 1460

CAS Number: 1037543-26-2

Notes: ATRA-BA hybrid is a mutual prodrug form of all-trans retinoic acid (ATRA; Item No. 11017) and butyric acid (BA; Item No. 13121).{57142} ATRA-BA hybrid is cleaved to release ATRA and BA in isolated mouse plasma. It inhibits the growth of MDA-MB-231 breast and PC3 prostate cancer cells with GI50 values of 0.01 and 1.02 µM, respectively. ATRA-BA (20 µM) has 15-fold greater antiproliferative activity in PC3 cells compared to an equimolar concentration of ATRA and BA.
More Information
SKU CAY30982-5
Manufacturer Cayman Chemical
Manufacturer SKU 30982-5
Package Unit 5 mg
Quantity Unit STK
Product information (PDF)
×
MSDS (PDF) Download